Business Standard

Jenburkt Pharmaceuticals Share Price

Know More

868.00-2.75 (-0.32%)

19th Jul 2024
Stock not traded

BSE : 524731


Sector : Health care

ISIN Code : INE354A01013

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 19-Jul-2024

Market Cap (₹ Cr)


Traded Value (₹ Cr)


Volume (Shares)


Face Value (₹)


52-Week High (₹)


52-Week High Date


52-Week Low (₹)


52-Week Low Date


All Time High (₹)


All Time High Date


All Time Low (₹)


All Time Low Date


Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd incorporated in 1985 was formed a venture to diversify into the healthcare and pharmaceutical industry by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1000 stockists and their reach extends to 400000+ pharmacies across the globe. The organisation caters to government semi-government institutions missionary hospitals public sector enterprises etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat ...
Read More

Jenburkt Pharmaceuticals Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)153.00
Latest Dividend Date 23-Jul-2024
Dividend Yield (%) 1.76
Book Value Share (₹) [S]328.42
P/B Ratio (₹) [S]2.64

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)



Week Low/High (₹)



Month Low/High (₹)



Year Low/High (₹)



All time Low/High (₹)



Share Price Returns

1 Week-1.56%%0.110.12%
1 Month1.46%%4.224.32%
3 Month17.46%%10.2810.76%
6 Month2.53%%12.4513.45%
1 Year15.43%%20.1323.69%
3 Year67.34%%53.3855.73%

Company Info

Company Information

Company Sec. & Compli. Officer : Ashish R Shah

Chairman & Managing Director : Ashish U Bhuta

Whole Time Director & CFO : Dilip H Bhuta

Non-Exec. & Independent Dir. : Hina Ravindra Mehta

Independent Director : Sumit Ajaybhai Thakkar

Independent Director : KRISHNAN SUBHARAMAN

Independent Director : PANKAJ .

Registered Office: Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W),Mumbai,Maharashtra-400058 Ph: 91-22-66943121/67603603


FAQs about Jenburkt Pharmaceuticals Ltd

1. What's the Jenburkt Pharmaceuticals Ltd share price today?
Jenburkt Pharmaceuticals Ltd share price was Rs 868.00 at close on 19th Jul 2024. Jenburkt Pharmaceuticals Ltd share price was down by 0.32% from the previous closing price of Rs 870.75. Jenburkt Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Jenburkt Pharmaceuticals Ltd share price moved up by 1.46% on BSE
  • Last 3 Months: Jenburkt Pharmaceuticals Ltd share price moved up by 17.46% on BSE
  • Last 12 Months: Jenburkt Pharmaceuticals Ltd share price moved up by 15.43% on BSE
  • Last 3 Years: Jenburkt Pharmaceuticals Ltd price moved up by 67.34% on BSE

2. How can I quickly analyse the performance of the Jenburkt Pharmaceuticals Ltd stock?
The performance of the Jenburkt Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 14.77
  • Price to book value ratio is 2.64
  • Dividend yield of 1.76
  • The EPS (trailing 12 months) of the Jenburkt Pharmaceuticals Ltd stock is Rs 58.76

3. What is the market cap of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd has a market capitalisation of Rs 383 crore.

4. What is Jenburkt Pharmaceuticals Ltd's 52-week high/low share price?
The Jenburkt Pharmaceuticals Ltd’s 52-week high share price is Rs 925.00 and 52-week low share price is Rs 586.90.

5. Is the Jenburkt Pharmaceuticals Ltd profitable?
On a consolidated basis, Jenburkt Pharmaceuticals Ltd reported a profit of Rs 7.88 crore on a total income of Rs 40.03 crore for the quarter ended 2024. For the year ended Mar 2024, Jenburkt Pharmaceuticals Ltd had posted a profit of Rs 7.88 crore on a total income of Rs 40.03 crore.

6. Which are Jenburkt Pharmaceuticals Ltd’s peers in the Health care sector?
Jenburkt Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Lyka Labs, Zenotech Lab., Fredun Pharma, Jenburkt Pharma, Kerala Ayurveda, Shukra Pharma., Trident Lifeline.

7. Who owns how much in Jenburkt Pharmaceuticals Ltd?
Key changes to the Jenburkt Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Jenburkt Pharmaceuticals Ltd has gone down to 46.71 per cent as of Jun 2024 from 47.42 per cent as of Sep 2023.